# Freshworks Inc.: financial statements, quarterly

FRSH · Nasdaq · CIK 1544522 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frsh.md) · [Financials](/companies/frsh/financials.md) · [Filings](/companies/frsh/filings.md) · [Insiders](/companies/frsh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frsh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [154](/filings/0001544522-24-000057.md) | [160 d](/filings/0001544522-26-000036.md) | [165](/filings/0001544522-25-000029.md) | [174](/filings/0001544522-25-000051.md) | [187](/filings/0001544522-25-000107.md) | [195 d](/filings/0001544522-26-000036.md) | [196](/filings/0001544522-26-000090.md) | [205](/filings/0001544522-26-000137.md) | [215](/filings/0001544522-25-000107.md) | [223 d](/filings/0001544522-26-000036.md) | [229](/filings/0001544522-26-000090.md) | [237](/filings/0001544522-26-000137.md) |
| Cost of revenue | $m | [26.3](/filings/0001544522-24-000057.md) | [27.0 d](/filings/0001544522-25-000010.md) | [25.9](/filings/0001544522-25-000029.md) | [28.2](/filings/0001544522-25-000051.md) | [29.8](/filings/0001544522-25-000107.md) | [29.5 d](/filings/0001544522-25-000010.md) | [29.9](/filings/0001544522-26-000090.md) | [31.1](/filings/0001544522-26-000137.md) | [33.0](/filings/0001544522-25-000107.md) | [32.2 d](/filings/0001544522-26-000036.md) | [34.7](/filings/0001544522-26-000090.md) | [36.1](/filings/0001544522-26-000137.md) |
| Gross profit | $m | [127](/filings/0001544522-24-000057.md) | [133 d](/filings/0001544522-26-000036.md) | [139](/filings/0001544522-25-000029.md) | [146](/filings/0001544522-25-000051.md) | [157](/filings/0001544522-25-000107.md) | [165 d](/filings/0001544522-26-000036.md) | [166](/filings/0001544522-26-000090.md) | [174](/filings/0001544522-26-000137.md) | [182](/filings/0001544522-25-000107.md) | [191 d](/filings/0001544522-26-000036.md) | [194](/filings/0001544522-26-000090.md) | [201](/filings/0001544522-26-000137.md) |
| Research and development | $m | [34.9](/filings/0001544522-24-000057.md) | [35.8 d](/filings/0001544522-26-000036.md) | [34.7](/filings/0001544522-25-000029.md) | [41.0](/filings/0001544522-25-000051.md) | [47.9](/filings/0001544522-25-000107.md) | [41.0 d](/filings/0001544522-26-000036.md) | [40.0](/filings/0001544522-26-000090.md) | [39.9](/filings/0001544522-26-000137.md) | [41.5](/filings/0001544522-25-000107.md) | [41.8 d](/filings/0001544522-26-000036.md) | [49.3](/filings/0001544522-26-000090.md) | [43.8](/filings/0001544522-26-000137.md) |
| Operating income | $m | [(38.7)](/filings/0001544522-24-000057.md) | [(40.0) d](/filings/0001544522-26-000036.md) | [(32.2)](/filings/0001544522-25-000029.md) | [(43.8)](/filings/0001544522-25-000051.md) | [(38.9)](/filings/0001544522-25-000107.md) | [(23.8) d](/filings/0001544522-26-000036.md) | [(10.4)](/filings/0001544522-26-000090.md) | [(8.7)](/filings/0001544522-26-000137.md) | [(7.5)](/filings/0001544522-25-000107.md) | [39.7 d](/filings/0001544522-26-000036.md) | [(8.1)](/filings/0001544522-26-000090.md) | [6.1](/filings/0001544522-26-000137.md) |
| Income tax | $m | [3.3](/filings/0001544522-24-000057.md) | [2.8 d](/filings/0001544522-26-000036.md) | [4.0](/filings/0001544522-25-000029.md) | [(10.4)](/filings/0001544522-25-000051.md) | [5.0](/filings/0001544522-25-000107.md) | [5.9 d](/filings/0001544522-26-000036.md) | [3.9](/filings/0001544522-26-000090.md) | [5.6](/filings/0001544522-26-000137.md) | [4.6](/filings/0001544522-25-000107.md) | [(145) d](/filings/0001544522-26-000036.md) | [(1.8)](/filings/0001544522-26-000090.md) | [7.0](/filings/0001544522-26-000137.md) |
| Net income | $m | [(31.0)](/filings/0001544522-24-000057.md) | [(28.1) d](/filings/0001544522-26-000036.md) | [(23.3)](/filings/0001544522-25-000029.md) | [(20.2)](/filings/0001544522-25-000051.md) | [(30.0)](/filings/0001544522-25-000107.md) | [(21.9) d](/filings/0001544522-26-000036.md) | [(1.3)](/filings/0001544522-26-000090.md) | [(1.7)](/filings/0001544522-26-000137.md) | [(4.7)](/filings/0001544522-25-000107.md) | [191 d](/filings/0001544522-26-000036.md) | [(4.8)](/filings/0001544522-26-000090.md) | [3.2](/filings/0001544522-26-000137.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001544522-24-000057.md) | not reported | [(0.08)](/filings/0001544522-25-000029.md) | [(0.07)](/filings/0001544522-25-000051.md) | [(0.10)](/filings/0001544522-25-000107.md) | not reported | [0.00](/filings/0001544522-26-000090.md) | [(0.01)](/filings/0001544522-26-000137.md) | [(0.02)](/filings/0001544522-25-000107.md) | not reported | [(0.02)](/filings/0001544522-26-000090.md) | [0.01](/filings/0001544522-26-000137.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001544522-24-000057.md) | not reported | [(0.08)](/filings/0001544522-25-000029.md) | [(0.07)](/filings/0001544522-25-000051.md) | [(0.10)](/filings/0001544522-25-000107.md) | not reported | [0.00](/filings/0001544522-26-000090.md) | [(0.01)](/filings/0001544522-26-000137.md) | [(0.02)](/filings/0001544522-25-000107.md) | not reported | [(0.02)](/filings/0001544522-26-000090.md) | [0.01](/filings/0001544522-26-000137.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [458](/filings/0001544522-24-000057.md) | [488](/filings/0001544522-26-000036.md) | [468](/filings/0001544522-25-000029.md) | [310](/filings/0001544522-25-000051.md) | [391](/filings/0001544522-25-000107.md) | [620](/filings/0001544522-26-000036.md) | [594](/filings/0001544522-26-000090.md) | [486](/filings/0001544522-26-000137.md) | [421](/filings/0001544522-25-000107.md) | [570](/filings/0001544522-26-000137.md) | [548](/filings/0001544522-26-000090.md) | [495](/filings/0001544522-26-000137.md) |
| Current assets | $m | [1,320](/filings/0001544522-23-000064.md) | [1,356](/filings/0001544522-25-000010.md) | [1,367](/filings/0001544522-24-000034.md) | [1,197](/filings/0001544522-24-000047.md) | [1,233](/filings/0001544522-24-000057.md) | [1,265](/filings/0001544522-26-000036.md) | [1,196](/filings/0001544522-25-000029.md) | [1,137](/filings/0001544522-25-000051.md) | [1,021](/filings/0001544522-25-000107.md) | [1,097](/filings/0001544522-26-000137.md) | [1,007](/filings/0001544522-26-000090.md) | [902](/filings/0001544522-26-000137.md) |
| Total assets | $m | [1,418](/filings/0001544522-23-000064.md) | [1,457](/filings/0001544522-25-000010.md) | [1,467](/filings/0001544522-24-000034.md) | [1,544](/filings/0001544522-24-000047.md) | [1,575](/filings/0001544522-24-000057.md) | [1,612](/filings/0001544522-26-000036.md) | [1,541](/filings/0001544522-25-000029.md) | [1,481](/filings/0001544522-25-000051.md) | [1,372](/filings/0001544522-25-000107.md) | [1,603](/filings/0001544522-26-000137.md) | [1,605](/filings/0001544522-26-000090.md) | [1,490](/filings/0001544522-26-000137.md) |
| Current liabilities | $m | [306](/filings/0001544522-23-000064.md) | [327](/filings/0001544522-25-000010.md) | [336](/filings/0001544522-24-000034.md) | [368](/filings/0001544522-24-000047.md) | [378](/filings/0001544522-24-000057.md) | [408](/filings/0001544522-26-000036.md) | [413](/filings/0001544522-25-000029.md) | [433](/filings/0001544522-25-000051.md) | [451](/filings/0001544522-25-000107.md) | [498](/filings/0001544522-26-000137.md) | [520](/filings/0001544522-26-000090.md) | [533](/filings/0001544522-26-000137.md) |
| Total liabilities | $m | [360](/filings/0001544522-23-000064.md) | [385](/filings/0001544522-25-000010.md) | [389](/filings/0001544522-24-000034.md) | [428](/filings/0001544522-24-000047.md) | [440](/filings/0001544522-24-000057.md) | [474](/filings/0001544522-26-000036.md) | [479](/filings/0001544522-25-000029.md) | [496](/filings/0001544522-25-000051.md) | [520](/filings/0001544522-25-000107.md) | [570](/filings/0001544522-26-000137.md) | [586](/filings/0001544522-26-000090.md) | [595](/filings/0001544522-26-000137.md) |
| Shareholders' equity | $m | [1,058](/filings/0001544522-24-000057.md) | [1,072](/filings/0001544522-26-000036.md) | [1,078](/filings/0001544522-25-000051.md) | [1,115](/filings/0001544522-25-000107.md) | [1,135](/filings/0001544522-25-000107.md) | [1,138](/filings/0001544522-26-000137.md) | [1,062](/filings/0001544522-26-000137.md) | [985](/filings/0001544522-26-000137.md) | [851](/filings/0001544522-25-000107.md) | [1,033](/filings/0001544522-26-000137.md) | [1,019](/filings/0001544522-26-000137.md) | [896](/filings/0001544522-26-000137.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.9 d](/filings/0001544522-24-000057.md) | [30.9 d](/filings/0001544522-26-000036.md) | [40.6](/filings/0001544522-25-000029.md) | [36.3 d](/filings/0001544522-25-000051.md) | [42.3 d](/filings/0001544522-25-000107.md) | [41.4 d](/filings/0001544522-26-000036.md) | [58.0](/filings/0001544522-26-000090.md) | [58.6 d](/filings/0001544522-26-000137.md) | [63.5 d](/filings/0001544522-25-000107.md) | [62.3 d](/filings/0001544522-26-000036.md) | [62.4](/filings/0001544522-26-000090.md) | [58.5 d](/filings/0001544522-26-000137.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001544522-24-000057.md) | [1.1 d](/filings/0001544522-26-000036.md) | [0.7](/filings/0001544522-25-000029.md) | [2.3 d](/filings/0001544522-25-000051.md) | [1.1 d](/filings/0001544522-25-000107.md) | [5.1 d](/filings/0001544522-26-000036.md) | [1.3](/filings/0001544522-26-000090.md) | [0.4 d](/filings/0001544522-26-000137.md) | [1.8 d](/filings/0001544522-25-000107.md) | [2.2 d](/filings/0001544522-26-000036.md) | [3.9](/filings/0001544522-26-000090.md) | [5.0 d](/filings/0001544522-26-000137.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001544522-25-000029.md) | [0.0 d](/filings/0001544522-25-000051.md) | [0.0 d](/filings/0001544522-25-000107.md) | [13.7 d](/filings/0001544522-26-000036.md) | [114](/filings/0001544522-26-000090.md) | [114 d](/filings/0001544522-26-000137.md) | [159 d](/filings/0001544522-25-000107.md) | [0.0 d](/filings/0001544522-26-000036.md) | [48.4](/filings/0001544522-26-000090.md) | [159 d](/filings/0001544522-26-000137.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [287](/filings/0001544522-23-000064.md) | [290](/filings/0001544522-24-000034.md) | [292](/filings/0001544522-24-000047.md) | [294](/filings/0001544522-24-000057.md) | [298](/filings/0001544522-25-000029.md) | [300](/filings/0001544522-25-000051.md) | [302](/filings/0001544522-25-000107.md) | [301](/filings/0001544522-26-000090.md) | [294](/filings/0001544522-26-000137.md) | [286](/filings/0001544522-25-000107.md) | [283](/filings/0001544522-26-000090.md) | [273](/filings/0001544522-26-000137.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.